Class IC Antiarrhythmic Drugs, Flecainide and Pilsicainide, Produce ST Segment Elevation Simulating Inferior Myocardial Ischemia
- 1 August 1998
- journal article
- case report
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 9 (8), 855-858
- https://doi.org/10.1111/j.1540-8167.1998.tb00125.x
Abstract
ST Elevation with Flecainide and Pilsicainide. Flecainide and pilsicainide, Class IC antiarrhythmic drugs with slow kinetics, were administered to a 64‐year‐old man experiencing ventricular tachycardia. Both drugs suppressed the arrhythmia, but caused ST segment elevation in leads II, III, and aVF. No evidence of ischemic heart disease was detected. Withdrawal of the drugs eliminated the ST change. Because these drugs frequently are used to treat tachyarrhythmias in patients who may present with chest pain, this rare ECG manifestation of Class IC drugs should he recognized to avoid misdiagnosis of acute interior myocardial infarction.Keywords
This publication has 13 references indexed in Scilit:
- β-Adrenergic Augmentation of Flecainide-Induced Conduction Slowing in Canine Purkinje FibersCirculation, 1997
- Discrepant drug action of disopyramide on ECG abnormalities and induction of ventricular arrhythmias in a patient with Brugada syndromeJournal of Electrocardiology, 1997
- Safety and Efficacy of Oral Flecainide Acetate in Patients with Cardiac Arrhythmias.Japanese Heart Journal, 1997
- Conversion of Recent-Onset Atrial Fibrillation by a Single Oral Dose of Pilsicainide (Pilsicainide Suppression Trial on Atrial Fibrillation)The American Journal of Cardiology, 1996
- Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndromeJournal of the American College of Cardiology, 1996
- Mechanisms of Negative Inotropic Effects of Class Ic Antiarrhythmic Agents: Comparative Study of the Effects of Flecainide and Pilsicainide on Intracellular Calcium Handling in Dog Ventricular MyocardiumJournal of Cardiovascular Pharmacology, 1996
- Electrophysiological Effects of MS‐551 in Humans: A Class III Antiarrhythmic AgentPacing and Clinical Electrophysiology, 1995
- Ischemia enhances use-Dependent sodium channel blockade by pilsicainide, a class IC antiarrhythmic agentJournal of the American College of Cardiology, 1994
- Flecainide-induced arrhythmia in canine ventricular epicardium. Phase 2 reentry?Circulation, 1993
- Heterogeneity within the ventricular wall. Electrophysiology and pharmacology of epicardial, endocardial, and M cells.Circulation Research, 1991